Nanjing Pharmaceutical Group Company Limited (SHA:600713)

Market Cap	8.38B +26.7%
Revenue (ttm)	54.96B +2.4%
Net Income	624.83M +9.5%
EPS	0.43 -2.7%
Shares Out	1.31B
PE Ratio	15.02
Forward PE	n/a
Dividend	0.17 (2.85%)
Ex-Dividend Date	Jun 30, 2025

Volume	132,015,251
Average Volume	38,343,264
Open	6.00
Previous Close	5.97
Day's Range	5.83 - 6.42
52-Week Range	4.75 - 6.65
Beta	0.37
RSI	63.89
Earnings Date	Apr 11, 2026

About SHA:600713

Nanjing Pharmaceutical Group Company Limited engages in the drug distribution businesses in China. It also involved in the wholesale and retail of medical device distribution; pharmaceutical logistics; and internet drug retail business. The company was formerly known as NanJing Pharmaceutical Company Limited and change its name to Nanjing Pharmaceutical Group Company Limited in December 2025. Nanjing Pharmaceutical Group Company Limited was founded in 1951 and is based in Nanjing, China.

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1951
• Employees: 4,830
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600713

Financial Performance

In 2025, SHA:600713's revenue was 54.96 billion, an increase of 2.36% compared to the previous year's 53.70 billion. Earnings were 624.83 million, an increase of 9.50%.